LQDA - צמיחת הכנסות שנתית ב-12 החודשים האחרונים Liquidia Corporation

Liquidia Corporation (LQDA) possesses significant pricing power thanks to its unique PRINT technology for lung therapy. This TTM year-over-year revenue chart visualizes income dynamics, where the value 798.40 captures this metric. Business stability relies on the patent protection of inhalation systems. A high retention rate of specialized engineers and scientists ensures the preservation of the company's key competencies.
Liquidia Technologies (LQDA) - פילוחי מדדים ודוחות פיננסיים

This indicator recalculates the percentage change in revenue over the last 12 months on a daily basis, eliminating time lags between quarterly reports. For Liquidia Corporation (LQDA), whose drugs exhibit inelastic demand, this trend reflects commercialization success regardless of market cycles. By analyzing the TTM year-over-year revenue growth rate, an investor assesses the effectiveness of business expansion. Steady growth confirms the resilience of fundamental positions and the reliability of patent protection.